Sarepta Therapeutics, Inc. SRPT Other Non-Current Assets
Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Sarepta Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sarepta Therapeutics, Inc.'s other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sarepta Therapeutics, Inc.'s other non-current assets?
- Sarepta Therapeutics, Inc. (SRPT) reported other non-current assets of $151.96M in Q1 2026.
- How has Sarepta Therapeutics, Inc.'s other non-current assets changed year-over-year?
- Sarepta Therapeutics, Inc.'s other non-current assets increased by 88.6% year-over-year, from $80.55M to $151.96M.
- What is the long-term trend for Sarepta Therapeutics, Inc.'s other non-current assets?
- Over 5 years (2020 to 2025), Sarepta Therapeutics, Inc.'s other non-current assets has grown at a -5.3% compound annual growth rate (CAGR), from $203.7M to $155.55M.
- What does other non-current assets mean?
- This category captures long-term assets that do not fit into standard classifications like property, plant, equipment, or intangible assets. It may include long-term deposits, deferred tax assets, or other miscellaneous non-current investments. It represents the residual value of long-term resources held by the company.